The approval and rollout of Mosquirix mark a significant milestone in the fight against malaria. However, continuous efforts are needed to improve vaccine efficacy, develop new vaccines, and optimize delivery systems. Research is ongoing to create second-generation malaria vaccines that offer higher efficacy and longer-lasting protection.
